Article(id=1325225309565485833, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224978404221808, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2026.02.004, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1753113600000, receivedDateStr=2025-07-22, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887935295, onlineDateStr=2026-11-05, pubDate=1770652800000, pubDateStr=2026-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887935295, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887935295, creator=13701087609, updateTime=1793887935295, updator=13701087609, issue=Issue{id=1325224978404221808, tenantId=1146029695717560320, journalId=1319690259887390882, year='2026', volume='57', issue='2', pageStart='145', pageEnd='256', issueExtLink='null', onlineDate='null', pubDate='1770652800000', pubDateStr='2026-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887856340, creator='13701087609', updateTime=1793946105114, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325469291528716508, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224978404221808, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325469291532910813, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1325224978404221808, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=167, endPage=172, ext={EN=ArticleExt(id=1325225309779395338, articleId=1325225309565485833, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Improved Synthetic Process of Ruxolitinib Phosphate, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=
An improved synthetic process of ruxolitinib phosphate(1) was developed. Starting from(4-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl) methyl pivalate(2) and 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole(3), [4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(5) was prepared via Suzuki-Miyaura coupling reaction. Compound 5 was deprotected by hydrochloric acid to afford [4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(6). Subsequent Michael addition of 6 with 3-cyclopentylacrylonitrile(4) furnished the racemic [4-[1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(7). Chiral resolution of 7 using D-(+)-dibenzoyl-L-tartaric acid[D-(+)-DBTA] afforded (2S, 3S)-2,3-Bis(benzoyloxy) succinate salt of (R)-[4-[1-(2-cyano-1-cyclopentylethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate(8). Deprotection and hydrolysis of 8 with sodium hydroxide yielded ruxolitinib(9). Finally, the target product 1 was available from 9 by salification reaction with phosphoric acid and recrystallization. The overall yield was 27% (based on 2), with the purity of 99.89% and the chiral purity of 99.88%, and the maximum single impurity less than 0.1%. The improved process features simple operation and has been verified by pilot-scale production, which was suitable for industrial production.
, authors=Naihua ZHANG, Weichen CUI, Anguo ZHU, Hao WEN, Guimin ZHANG
*, authorsList=Naihua ZHANG, Weichen CUI, Anguo ZHU, Hao WEN, Guimin ZHANG, authorCompany=null, correspAuthors=Guimin ZHANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325225311608111883, articleId=1325225309565485833, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=磷酸芦可替尼的合成工艺优化, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
对磷酸芦可替尼(1)的合成工艺进行了改进与优化。以(4-氯-7H-吡咯并[2,3-d]嘧啶-7-基)甲基特戊酸酯(2)和1-(1-乙氧基乙基)-4-(4,4,5,5-四甲基-1,3,2-二氧杂戊硼烷-2-基)-1H-吡唑(3)为起始物料,经Suzuki-Miyaura偶联反应制得[4-[1-(1-乙氧基乙基)-1H-吡唑-4-基]-7H-吡咯并[2,3-d]嘧啶-7-基]甲基特戊酸酯(5),5经盐酸水解生成[4-(1H-吡唑-4-基)-7H-吡咯并[2,3-d]嘧啶-7-基]甲基特戊酸酯(6),6与3-环戊基丙烯腈(4)经Michael加成反应得到外消旋[4-[1-(2-氰基-1-环戊基乙基)-1H-吡唑-4-基]-7H-吡咯并[2,3-d]嘧啶-7-基]甲基特戊酸酯(7),7经D-(+)-二苯甲酰酒石酸一水合物拆分得(2S,3S)-2,3-双(苯甲酰氧基)琥珀酸-(R)-[4-[1-(2-氰基-1-环戊基乙基)-1H-吡唑-4-基]-7H-吡咯并[2,3-d]嘧啶-7-基]甲基特戊酸酯(8),8经氢氧化钠游离并水解制得芦可替尼(9),最后与磷酸成盐并精制,得目标产品1。该工艺总收率27%(以2计),所得产物纯度为99.89%,手性纯度99.88%,最大单杂小于0.1%。改进后的工艺操作简便,已通过中试放大验证,适合工业化生产。
, authors=张乃华, 崔维琛, 朱安国, 文浩, 张贵民
*, authorsList=张乃华, 崔维琛, 朱安国, 文浩, 张贵民, authorCompany=null, correspAuthors=张贵民, authorNote=
, correspAuthorsNote=
张贵民,研究员,从事药物研发及工程化研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=gs7aLUH4mtdj8/9NIqQPKw==, magXml=9fXeXicTKQin/cm6gtUUXA==, pdfUrl=null, pdf=DqRVphtg1oQj0ZodqCj6Sg==, pdfFileSize=1057866, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Z9wnCEr9XYDrtO13mRT+og==, mapNumber=null, fund=null)}, authors=[Author(id=1325225311947850512, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225312040125202, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225311947850512, language=EN, stringName=Naihua ZHANG, firstName=Naihua, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225312107234067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225311947850512, language=CN, stringName=张乃华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio={"content":"
张乃华,工程师,从事仿制药物研究。
"}, bioImg=null, bioContent=
张乃华,工程师,从事仿制药物研究。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1325225312191120149, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225312270811927, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312191120149, language=EN, stringName=Weichen CUI, firstName=Weichen, middleName=null, lastName=CUI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225312337920792, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312191120149, language=CN, stringName=崔维琛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1325225312430195482, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225312539247388, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312430195482, language=EN, stringName=Anguo ZHU, firstName=Anguo, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225312606356253, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312430195482, language=CN, stringName=朱安国, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1325225312715408159, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325225312799294241, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312715408159, language=EN, stringName=Hao WEN, firstName=Hao, middleName=null, lastName=WEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225312883180322, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312715408159, language=CN, stringName=文浩, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])]), Author(id=1325225312979649316, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325225313055146790, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312979649316, language=EN, stringName=Guimin ZHANG, firstName=Guimin, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325225313118061351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, authorId=1325225312979649316, language=CN, stringName=张贵民, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
*, address=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])])], keywords=[Keyword(id=1325225313231307560, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=EN, orderNo=1, keyword=ruxolitinib phosphate), Keyword(id=1325225313315193641, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=EN, orderNo=2, keyword=Janus kinase inhibitor), Keyword(id=1325225313378108202, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=EN, orderNo=3, keyword=primary myelofibrosis), Keyword(id=1325225313445217067, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=EN, orderNo=4, keyword=synthetic process), Keyword(id=1325225313520714540, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=CN, orderNo=1, keyword=磷酸芦可替尼), Keyword(id=1325225313600406317, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=CN, orderNo=2, keyword=Janus激酶抑制剂), Keyword(id=1325225313667515182, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=CN, orderNo=3, keyword=原发性骨髓纤维化), Keyword(id=1325225313738818351, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, language=CN, orderNo=4, keyword=合成工艺)], refs=[Reference(id=1325225313843675952, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=陈洪斌, 成 碟, 林 义, 等.一种芦可替尼的制备方法: 中国, 114456181A [P].2022-05-10., articleTitle=null, refAbstract=null), Reference(id=1325225313910784817, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=王 永, 刘利刚, 项 杰, 等.一种鲁索利替尼中间体的合成方法: 中国, 104496904A [P].2015-04-08., articleTitle=null, refAbstract=null), Reference(id=1325225313986282290, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=陈甫雪, 夏 定, 邹万智, 等.鲁索替尼中间体(
R)-3-(4-溴-1
H-吡唑-1-基)-3-环戊基丙腈的合成方法: 中国,105461630A [P].2016-04-06., articleTitle=null, refAbstract=null), Reference(id=1325225314078556979, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=邱炳林, 钟宝香, 陈华栋, 等.鲁索替尼中间体(
R)-3-(4-溴-1
H-吡唑-1-基)-3-环戊基丙腈的制备方法: 中国,107674026A [P].2018-02-09., articleTitle=null, refAbstract=null), Reference(id=1325225314145665844, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=陈 强, 凌 凯, 秦小飞, 等.鲁索替尼中间体(
R)-3-(4-卤代-1
H-吡唑-1-基)-3-环戊基丙酸酯的制备方法: 中国,114214375A [P].2022-03-22., articleTitle=null, refAbstract=null), Reference(id=1325225315802415925, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN Q Y, WANG H S, LI M,
et al.Processes for preparing JAK inhibitors and related intermediate compounds: WO, 2010083283A2 [P].2010-07-22., articleTitle=null, refAbstract=null), Reference(id=1325225315915662134, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LIN Q Y, DAVID M, PAN Y C,
et al.Enantioselective synthesis of janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction [J].
Org Lett, 2009,
11(9): 1999-2002., articleTitle=null, refAbstract=null), Reference(id=1325225315991159607, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=李文婕, 宋 颢.高光学纯度INCB018424的合成[J].合成化学, 2011,
19(2): 280-282., articleTitle=null, refAbstract=null), Reference(id=1325225316070851384, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=HAYDL A M, XU K, Breit B.Regio- and enantioselective synthesis of
N-substituted pyrazoles by rhodium-catalyzed asymmetric addition to allenes [J].
Angew Chem Int Ed, 2015,
54(24): 7149-7153., articleTitle=null, refAbstract=null), Reference(id=1325225316167320377, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=ESWARAIAH S, THIRUMALAI R S, VENKATA P R G.Process for the preparation of (
R)-3-[4-(7
H-pyrrolo[2,3-
d]-pyrimidin-4-yl)-1
H-pyrazol-1-yl]-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof: WO, 2016063294A2[P].2016-04-28., articleTitle=null, refAbstract=null), Reference(id=1325225316267983674, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=朱怡君, 金生华, 钱 凯, 等.一种JAK抑制剂的制备方法:中国, 113292569A [P].2021-08-24., articleTitle=null, refAbstract=null), Reference(id=1325225316351869755, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=陈 浩, 周勤益, 陈 帮, 等.一种芦可替尼及其中间体的制备方法: 中国, 118852013A [P]. 2024-10-29., articleTitle=null, refAbstract=null), Reference(id=1325225316456727356, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=戚聿新, 孟鲁波, 杨玉梅, 等.一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-
d]嘧啶的简便合成方法: 中国, 109651424A[P].2019-04-19., articleTitle=null, refAbstract=null), Reference(id=1325225316515447613, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=因塞特公司.作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-
b]吡咯和吡咯并[2,3-
b]嘧啶: 中国, 101448826A[P].2009-06-03., articleTitle=null, refAbstract=null), Reference(id=1325225316586750782, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=SILVERMAN I R, LIU J, MORGAN A J.Deuterated derivatives of ruxolitinib: WO, 2013188783A1 [P].2013-12-19., articleTitle=null, refAbstract=null), Reference(id=1325225316645471039, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=RAJAN S T, ESWARAIAH S, RAO G V P,
et al.Improved process for the preparation of (
R)-3-(4-(7
H-pyrrolo[2,3
d]pyrimidin-4-yl)-1
H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate: IN, 201741043524A [P].2019-06-07., articleTitle=null, refAbstract=null), Reference(id=1325225316716774208, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=张喜全, 张爱明, 周 舟, 等.一种芦可替尼的合成工艺: 中国, 108699063A [P].2018-10-23., articleTitle=null, refAbstract=null), Reference(id=1325225316800660289, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU J C, CHEN S L, LIU P L,
et al.Process and intermediates for preparing a JAK inhibitor: WO, 2022040180A1 [P].2022-02-24., articleTitle=null, refAbstract=null), Reference(id=1325225316897129282, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=贾忠将, 刘卫国, 刘平里, 等.JAK抑制剂的固体形式和其制备方法: 中国, 119677746A [P],2025-03-21., articleTitle=null, refAbstract=null), Reference(id=1325225316964238147, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=曹 标, 朱杭杭, 吴建忠, 等.一种JAK抑制剂及其盐的制备方法: 中国, 107759601A [P].2018-03-06., articleTitle=null, refAbstract=null), Reference(id=1325225317337531204, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=康塞特医药品有限公司.用于制备对映异构体富集的JAK抑制剂的方法: 中国, 113906032A [P].2022-01-07., articleTitle=null, refAbstract=null), Reference(id=1325225317459166021, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LEWIS R S, KARLA M R,
et al.Process for Preparing Enantiomerically Enriched JAK Inhibitors: US, 20220213105A1 [P].2022-07-07., articleTitle=null, refAbstract=null), Reference(id=1325225317530469190, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=周家成, 刘平礼, 林琦彦, 等.制备JAK抑制剂及相关中间化合物的方法: 中国, 102348693A [P].2012-02-08., articleTitle=null, refAbstract=null), Reference(id=1325225317656298311, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=太阳制药工业股份有限公司.卢索替尼的氘代衍生物: 中国, 104725380A [P].2015-06-24., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325225311855575820, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, xref=null, ext=[AuthorCompanyExt(id=1325225311863964429, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=National Engineering and Technology Research Center of Chirality Pharmaceutical, Shandong New Time Pharmaceutical Co., Ltd., Linyi 273400), AuthorCompanyExt(id=1325225311872353038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1325225309565485833, companyId=1325225311855575820, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东新时代药业有限公司,国家手性制药工程技术研究中心,山东 临沂 273400)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2026.02.004, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.02.004, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2026.02.004, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2026.02.004, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1770652800000, fullTextJson=null, articleText=null, reference=null)